Immune responses and pulmonary function were assessed as part of a NIOSH Health Hazards Evaluation in 36 workers involved in the production of industrial enzymes from bacteria and fungi following complaints of asthma and flu like symptoms. Environmental exposure was assessed by measuring the activities of alkaline-protease and amyloglucosidase and total protein in air samples. Workers were examined using epicutaneous threshold titration testing, enzyme linked immunosorbent assay of blood samples, and pulmonary function tests. Exposed workers had significant increases in the prevalence of respiratory, ocular, nasal irritation, and flu like symptoms as well as in sweating and muscle aches. Forty two percent of the subjects reported having two or more symptoms associated with allergies and 25% had two or more symptoms associated with a flu like illness. Significant increases were seen in the percentage of workers with positive skin reactions to selected antigens, 50% had positive skin reactions to commercial alkaline-protease, 22% reacted to commercial amyloglucosidase from Aspergillus-niger (AGAn), and 22% reacted to amyloglucosidase from noncommercial A-niger (CAGAn). The number of workers identified as atopic was significantly increased as well. Significant increases in mean IgG specific antibody levels for alpha amylases from B-licheniformis, B-subtilis formulation 1, B-subtilis formulation 2, commercial A-oryzae (CaAAo), AGAn, and CAGAn and in mean serum IgE specific antibodies for CaAAo and AGAn were seen among exposed workers compared with referents. An increased risk for mild obstructive or restrictive results on lung function testing was seen among process operators and a significant number of workers tested positive for asthma using peak flow determination. The authors conclude that occupational exposure to industrial enzymes may induce cutaneous hypersensitivity, increase antibody levels, and alter lung function.
Raymond E. Biagini, National Institute for Occupational Safety and Health, Division of Biomedical and Behavioral Science, Applied Biology Branch. Immunochemistry Research Section. Cincinnati, OH 45226, USA
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.